-
Amorim JH, Alves RP, Boscardin SB, Ferreira LC, 2014: The dengue virus non-structural 1 protein: risks and benefits[J]. Virus Res, 181, 53-60. doi: 10.1016/j.virusres.2014.01.001
-
Ashour J, Laurent-Rolle M, Shi PY, Garcia-Sastre A, 2009: NS5 of dengue virus mediates STAT2 binding and degradation[J]. J Virol, 83, 5408-5418. doi: 10.1128/JVI.02188-08
-
Best SM, 2017: The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling[J]. J Virol, 91, e01970-16.
-
Blitvich BJ, Scanlon D, Shiell BJ, Mackenzie JS, Hall RA, 1999: Identification and analysis of truncated and elongated species of the flavivirus NS1 protein[J]. Virus Res, 60, 67-79. doi: 10.1016/S0168-1702(99)00003-9
-
Dalrymple NA, Cimica V, Mackow ER, 2015: Dengue virus NS proteins inhibit RIG-I/MAVS signaling by blocking TBK1/IRF3 phosphorylation: dengue virus serotype 1 NS4A Is a unique interferon-regulating virulence determinant[J]. mBio, 6, e00553-00515.
-
Daniels BP, Snyder AG, Olsen TM, Orozco S, Oguin TH, Tait SWG, Martinez J, Gale M, Loo YM, Oberst A, 2017: RIPK3 restricts viral pathogenesis via cell death-independent neuroinflammation[J]. Cell, 169, 301-313. doi: 10.1016/j.cell.2017.03.011
-
Firth AE, Atkins JF, 2009: A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese Encephalitis flaviviruses suggests NS1' may derive from ribosomal frameshifting[J]. Virol J, 6, 14-. doi: 10.1186/1743-422X-6-14
-
Ginsburg AS, Meghani A, Halstead SB, Yaich M, 2017: Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: a review of safety and tolerability studies[J]. Hum Vaccin Immunother, 13, 2222-2231. doi: 10.1080/21645515.2017.1356496
-
Grant A, Ponia SS, Tripathi S, Balasubramaniam V, Miorin L, Sourisseau M, Schwarz MC, Sanchez-Seco MP, Evans MJ, Best SM, Garcia-Sastre A, 2016: Zika virus targets human STAT2 to inhibit type I interferon signaling[J]. Cell Host Microbe, 19, 882-890. doi: 10.1016/j.chom.2016.05.009
-
Igarashi A, Tanaka M, Morita K, Takasu T, Ahmed A, Akram DS, Waqar MA, 1994: Detection of West Nile and Japanese Encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan[J]. Microbiol Immunol, 38, 827-830. doi: 10.1111/mim.1994.38.issue-10
-
Johansen CA, van den Hurk AF, Pyke AT, Zborowski P, Phillips DA, Mackenzie JS, Ritchie SA, 2001: Entomological investigations of an outbreak of Japanese Encephalitis virus in the Torres Strait, Australia, in 1998[J]. J Med Entomol, 38, 581-588. doi: 10.1603/0022-2585-38.4.581
-
Mackenzie JS, 2005: Emerging zoonotic encephalitis viruses: lessons from Southeast Asia and Oceania[J]. J Neurovirol, 11, 434-440. doi: 10.1080/13550280591002487
-
Mackenzie JS, Gubler DJ, Petersen LR, 2004: Emerging flaviviruses: the spread and resurgence of Japanese Encephalitis, West Nile and Dengue viruses[J]. Nat Med, 10, S98-S109. doi: 10.1038/nm1144
-
Melian EB, Hinzman E, Nagasaki T, Firth AE, Wills NM, Nouwens AS, Blitvich BJ, Leung J, Funk A, Atkins JF, Hall R, Khromykh AA, 2010: NS1' of flaviviruses in the Japanese Encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness[J]. J Virol, 84, 1641-1647. doi: 10.1128/JVI.01979-09
-
Mitchell CJ, Savage HM, Smith GC, Flood SP, Castro LT, Roppul M, 1993: Japanese Encephalitis on Saipan: a survey of suspected mosquito vectors[J]. Am J Trop Med Hyg, 48, 585-590. doi: 10.4269/ajtmh.1993.48.585
-
Morita K, Nabeshima T, Buerano CC, 2015: Japanese encephalitis[J]. Rev Sci Tech, 34, 441-452. doi: 10.20506/rst.issue.34.1.58
-
Muller DA, Young PR, 2013: The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker[J]. Antiviral Res, 98, 192-208. doi: 10.1016/j.antiviral.2013.03.008
-
Rastogi M, Sharma N, Singh SK, 2016: Flavivirus NS1: a multifaceted enigmatic viral protein[J]. Virol J, 13, 131-. doi: 10.1186/s12985-016-0590-7
-
Snell LM, Brooks DG, 2015: New insights into type I interferon and the immunopathogenesis of persistent viral infections[J]. Curr Opin Immunol, 34, 91-98. doi: 10.1016/j.coi.2015.03.002
-
Sucharit S, Surathin K, Shrestha SR, 1989: Vectors of Japanese Encephalitis virus (JEV): species complexes of the vectors[J]. Southeast Asian J Trop Med Public Health, 20, 611-621.
-
Teijaro JR, 2016: Type I interferons in viral control and immune regulation[J]. Curr Opin Virol, 16, 31-40. doi: 10.1016/j.coviro.2016.01.001
-
Turtle L, Driver C, 2018: Risk assessment for Japanese Encephalitis vaccination[J]. Hum Vaccin Immunother, 14, 213-217. doi: 10.1080/21645515.2017.1380756
-
Turtle L, Solomon T, 2018: Japanese encephalitisjthe prospects for new treatments[J]. Nat Rev Neurol, 14, 298-313. doi: 10.1038/nrneurol.2018.30
-
Unni SK, Ruzek D, Chhatbar C, Mishra R, Johri MK, Singh SK, 2011: Japanese encephalitis virus: from genome to infectome[J]. Microb Infect, 13, 312-321. doi: 10.1016/j.micinf.2011.01.002
-
Urosevic N, 2003: Is flavivirus resistance interferon type I-independent?[J]. Immunol Cell Biol,, 81, 224-229. doi: 10.1046/j.1440-1711.2003.01156.x
-
van den Hurk AF, Ritchie SA, Mackenzie JS, 2009: Ecology and geographical expansion of Japanese Encephalitis virus[J]. Annu Rev Entomol, 54, 17-35. doi: 10.1146/annurev.ento.54.110807.090510
-
Wang J, Li X, Gu J, Fan Y, Zhao P, Cao R, Chen P, 2015: The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection[J]. Infect Genet Evol, 36, 116-125. doi: 10.1016/j.meegid.2015.09.013
-
Ye Q, Li XF, Zhao H, Li SH, Deng YQ, Cao RY, Song KY, Wang HJ, Hua RH, Yu YX, Zhou X, Qin ED, Qin CF, 2012: A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1' formation and contributes to attenuation[J]. J Gen Virol, 93, 1959-1964. doi: 10.1099/vir.0.043844-0
-
Young LB, Melian EB, Khromykh AA, 2013: NS1' colocalizes with NS1 and can substitute for NS1 in West Nile virus replication[J]. J Virol, 87, 9384-9390. doi: 10.1128/JVI.01101-13
-
Young LB, Melian EB, Setoh YX, Young PR, Khromykh AA, 2015: Last 20 aa of the West Nile virus NS1' protein are responsible for its retention in cells and the formation of unique heat-stable dimers[J]. J Gen Virol, 96, 1042-1054. doi: 10.1099/vir.0.000053
-
Zhang HL, Ye HQ, Liu SQ, Deng CL, Li XD, Shi PY, Zhang B, 2017: West Nile Virus NS1 antagonizes interferon beta production by targeting RIG-I and MDA5[J]. J Virol, , e02396-16.